New combo aims to wipe out lingering leukemia cells before they return
Disease control
Recruiting now
This study tests whether a new combination of three drugs (tagraxofusp, azacitidine, and venetoclax) can safely eliminate leftover leukemia cells that are not visible under a microscope in adults with acute myeloid leukemia (AML). These hidden cells can cause the cancer to come b…
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 15, 2026 11:57 UTC